Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis

Digestive Diseases and Sciences

Volumn 49, Issue 4, 2004, Pages 611-618

  Czaja, Albert J ^a   Shums, Zakera ^c   Donaldson, Peter T ^b   Norman, Gary L ^c  

^a MAYO CLINIC   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c INOVA DIAGNOSTICS INC   (United States)

Author keywords

Antibodies; Celiac disease; Colitis; Hepatitis

Indexed keywords

CORTICOSTEROID; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; PREDNISONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; ANTINUCLEAR ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESPONSE; ENZYME IMMUNOASSAY; FEMALE; HEREDITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUCOSA; OUTCOMES RESEARCH; PATIENT; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SAMPLE; SEROLOGY; TISSUE LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; PROBABILITY; REFERENCE VALUE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, FUNGAL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; SACCHAROMYCES CEREVISIAE; SEROLOGIC TESTS; TREATMENT OUTCOME;

EID: 2942720855     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000026306.36511.c8     Document Type: Article

References (51)

1. Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, Lucidarme D, Camus D, Poulain D: Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diag Lab Immunol 3:219-226, 1996
2. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Parratt D: Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. BMJ 297:1105-1106, 1988
3. Giaffer MH, Clark A, Holdsworth CD: Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 33:1071-1075, 1992
4. Quinton J-F, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel J-F, Poulain D: Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantiantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788-791, 1998
5. Norman GL: Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease. Clin Applied Immunol Rev 2:45-63, 2001
6. Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russ MG, Forget PP, Tervaert JW: Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: High prevalence in patients with celiac disease. J Clin Immunol 22:281-288, 2002
7. Krause I, Monselise Y, Milo G, Weinberger A: Anti-Saccharomyces cerevisiae antibodies: A novel serologic marker for Behcet's disease. Clin Exp Rheumatol 20:S21-S24, 2002
8. Kim BG, Kim YS, Kim JS, Jung HC, Song IS: Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum 45:1062-1069, 2002
9. Hoffman IEA, Demetter P, Peeters M, De Vos M, Mielants H, Veys EM, De Keyser F: Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 62:455-459, 2003
10. Reddy RK, Colombel J-F, Poulain D, Krawitt EL: Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease [letter to the editor]. Am J Gastroenterol 96:252-253, 2001
11. Muratori P, Muratori L, Guidi M, Maccariello S, Pappas G, Ferrari R, Gionchetti P, Campieri M, Bianchi FB: Anti-Saccharomyces cerevisiae antibosies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 132:473-476, 2003
12. Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, Lenzi M, Bianchi FB, Czaja AJ: Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 43:2190-2195, 1998
13. Perdigoto R, Carpenter HA, Czaja AJ: Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 14:325-331, 1992
14. Czaja AJ: Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 96:1224-1231, 2001
15. Sendid B, Quinton J-F, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel J-F: Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 93:1306-1310, 1998
16. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J: Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 46:58-63, 2000
17. Annese V, Andreoli A, Andriulli A, D'Inca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF: Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol 96:2407-2412, 2001
18. Glas J, Torok HP, Vilsmaier F, Herbinger KH, Hoelscher M, Folwaczny C: Ant-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value. Digestion 66:173-177, 2002
19. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 18:816-822, 1993
20. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R: Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701-706, 1991
21. Tighe MR, Hall MA, Cardi E, Ashkenazi A, Lanchbury JS, Ciclitira PJ: Associations between alleles of the major histocompatibility complex-encoded ABC transporter TAP2, HLA class II alleles, and celiac disease susceptibility. Hum Immunol 39:9-16, 1994
22. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg J-C, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, Mcrarlane IG, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938, 1999
23. Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology 36:479-497, 2002
24. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF: Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85:713-717, 1983
25. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24:1068-1073, 1996
26. Czaja AJ, Nishioka M, Morshed SA, Hachiya T: Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107:200-207, 1994
27. Homburger HA, Cahen YD, Griffiths J, Jacob GL: Detection of antinuclear antibodies. Comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med 122:993-999, 1998
28. Czaja AJ, Manns MP, Homburger HA: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103:1290-1295, 1992
29. Czaja AJ: Treatment of autoimmune hepatitis. Semin Liver Dis 22:365-377, 2002
30. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: Dose titration, standard dose, and combination with azathioprine compared. Gut 16:876-883, 1975
31. Czaja AJ, Wolf AM, Baggenstoss AH: Laboratory assessment of severe chronic active liver disease (CALD): correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology 80:687-692, 1981
32. Czaja AJ, Menon KVN, Carpenter HA: Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 35:890-897, 2002
33. DiMagno EP, Corle D, O'Brien JF, Masnyk IJ, Go VLW, Aamodt R: Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 64:1226-1234, 1989
34. Wong RC, Wilson RJ, Steele RH, Radford-Smith G, Adelstein S: A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 55:488-494, 2002
35. Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, Panfili E, Notarbartolo A, Montalto G: Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 49:506-511, 2001
36. Lerner A, Kumar V, Iancu TC: Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol 95:78-82, 1994
37. Cummins A, Thompson F: Sensitivity of anti-endomysial antibody in detecting celiac disease. Gastroenterology 122:246-247, 2002
38. Gomez JC, Selvaggio G, Pizarro B, Viola MJ, Motta GL, Smecuol E, Castelletto R, Echeverria R, Vazquez H, Mazure R, Crivelli A, Sugai E, Maurino E, Bai JC: Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol 97:2785-2790, 2002
39. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25:317-323, 1997
40. Vermeire S, Peeters M, Vlietinck, Joossens S, Hond ED, Bulteel V, Bossuyt X, Geypens B, Rutgeerts: Anti-Saccharmyces cerevesiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflam Bowel Dis 7:8-15, 2001
41. Ikuno N, Mackay IR, Jois J, Omagari K, Rowley MJ: Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J Gastroenterol Hepatol 16:1390-1394, 2001
42. Reynoso-Paz S, Leung PS, Van de Water J, Tanaka A, Munoz S, Bass N, Lindor K, Donald PJ, Coppel RL, Ansari AA, Gershwin ME: Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 31:24-29, 2000
43. Tanaka A, Nalbandian G, Leung PS, Benson GD, Munoz S, Findor JA, Branch AD, Coppel RL, Ansari AA, Gershwin ME: Mucosal immunity and primary biliary cirrhosis: Presence of antimitochondrial antibodies in urine. Hepatology 32:910-915, 2000
44. Greenberg CS, Birckbichler PL, Rice RH: Transglutaminases: Multifactorial cross-linking enzymes that stabilize tissues. FASEB J 5:3071-3077, 1991
45. Piacentini M: Tissue transglutaminase: A candidate effector element of physiological cell death. Curr Top Microbiol Immunol 200:163-175, 1995
46. Small K, Feng JF, Lorenz J, Donnelly ED, Yu A, Im MJ, Dorn GE 2nd, Liggett SB: Cardiac specific overexpression of transglutaminase II (Gh) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem 274:21291-21296, 1999
47. Peracchi M, Trovato C, Longhi M, Gasparin M, Conte D, Tarantino C, Prati D, Bardella MT: Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol 97:2850-2854, 2002
48. Feighery L, Collins C, Feighery C, Mahmud N, Coughlan G, Willoughby R, Jackson J: Anti-transglutaminase antibodies and the serological diagnosis of coeliac disease. Br J Biochem Sci 60:14-18, 2003
49. Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, De Franchis R: High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 38:50-54, 2003
50. Horvath K, Hill ID: Anti-tissue transglutaminase antibody as the first line screening for celiac disease: Good-bye antigliadin tests? Am J Gastroenterol 97:2702-2704, 2002
51. Green PH, Barry M, Matsutani M: Serologic tests for celiac disease. Gastroenterology 124:585-586, 2003